This session will be 9:30AM to 11:00AM Munich time.
Women need a range of HIV prevention options to meet different needs, preferences and life circumstances. Currently available pills, rings and injectables are necessary but insufficient. How might we accelerate the delivery of methods we have while developing additional ones – including systemic and non-systemic methods, short-acting and on-demand products, to complement longer-acting ones? Product developers and advocates are collaborating on new approaches to expedite R&D of additional HIV prevention options. Notably, MATRIX is taking a unique approach, endorsed by the CASPR network of advocates, that aims to improve the odds of success of new products – through development, delivery and use.
This session will focus on new efforts to identify and develop promising options, strategically engage all stakeholders, decolonize R&D and involve potential users in all their diversities throughout the process.
Speakers:
- Jeanne Marrazzo, National Institute of Allergy and Infectious Diseases
- Sharon Hillier, University of Pittsburgh / Magee-Womens Research Institute
- Thesla Palanee-Phillips, Wits RHI
Followed by a moderated panel with:
- Chimwemwe Chamdimba, African Medicines Regulatory Harmonization (AMRH) initiative- AUDA/NEPAD
- Kelly Chibale, Holistic Drug Discovery and Development Centre -H3D, University of Cape Town
- Nyaradzo Mgodi, University of Zimbabwe- Harare Health Research Centre
- Jerop Ruth Limo, Ambassador for Youth and Adolescents Reproductive Health Program (AYARHEP)
Moderators:
- Navita Jain, AVAC
- Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology
Session Chairs:
- Sharon Hillier, University of Pittsburgh / Magee-Womens Research Institute
- Imelda Mahaka, Pangaea Zimbabwe
This satellite session will be co-hosted by CASPR and MATRIX, with support from USAID and PEPFAR.